# A Study to Investigate the Effect of PH-797804 on QTc Interval

> **NCT01862887** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PH-797804
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01862887
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862887, "A Study to Investigate the Effect of PH-797804 on QTc Interval". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01862887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*